Yale Cancer Center and School of Public Health Receive Grant to Study Lifestyle Intervention in Women with Ovarian Cancer
The National Cancer Institute recently awarded Yale Cancer Center and Yale School of Public Health a new U01 cooperative agreement grant to support research into the impact of diet and exercise for women with ovarian cancer.
Yale Gynecologic Pathologists Are Pioneers in Clinical Validation and Application of Molecular Genotyping for Gestational Trophoblastic Disease
Yale Pathology’s experienced gynecological pathologists are pioneers in the clinical validation and application of molecular genotyping for gestational trophoblastic disease (GTD).
Angelique W. Levi, MD, in Honor of Cervical Health Awareness Month
In recognition of Cervical Health Awareness Month, Dr. Angelique Levi, Associate Professor of Pathology; Vice Chair of Pathology; and Director, Yale Pathology Outreach Program, shares the importance of prevention and screening for cervical cancer, and how she collaborates with others at Yale Cancer Center and Smilow Cancer Hospital.
Pill Not Enough for 'Sexual Problems' Female Cancer Patients Face
Using the Female Sexual Function Index (FSFI) as a measurement tool, investigators found that desire scores were not significantly different for participants who received the antidepressant bupropion versus a placebo over a 9-week study period.Source: Medscape
Potential Therapy to Prevent, Treat Endometrial Cancer Recurrence
Researchers have found that endocrine-targeted therapies and an assessment of biomarkers in sex hormone and insulin signalling pathways may be useful in the prevention and treatment of endometrial cancer recurrence.Source: The Statesman